Giorgio Brembilla

10PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyNephrology and urologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.

|Apr 30, 2026
PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI.

|Feb 21, 2026
Diagnostic performance of the clear cell likelihood score (ccLS) for small renal masses characterization in patients undergoing percutaneous biopsy.

Giorgio Brembilla, Renato Pennella, Gianluca Siciliano

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Dec 24, 2024
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI.

Giorgio Brembilla, Giuseppe Basile, Michele Cosenza

|Sep 06, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.

Chiara Mercinelli, Marco Moschini, Antonio Cigliola

Pageof 2

Frequent Collaborators

3 joint publications

Andrea Necchi

3 joint publications

Francesco De Cobelli

3 joint publications

Chiara Mercinelli

3 joint publications

Antonio Cigliola